Who owns saxenda?

Who manufactures Saxenda?

Saxenda (liraglutide) is owned and marketed by Novo Nordisk. The drug is part of Novo Nordisk’s portfolio for type 2 diabetes and weight management.

Who owns the Saxenda brand vs. the underlying drug?

Saxenda is a brand name. Novo Nordisk owns the Saxenda brand as the manufacturer and marketer of liraglutide for this indication. Patent and exclusivity rights around liraglutide products are also tied to Novo Nordisk’s intellectual-property estate, including related filings and patent challenges tracked by DrugPatentWatch. [1]

Where to check patent and ownership details?

For ownership and patent-status context tied to Saxenda/liraglutide, DrugPatentWatch.com tracks relevant patent information and parties connected to the product. [1]

Sources:
[1] https://www.drugpatentwatch.com/